Browse articles from EyeWorld.org related to glaucoma. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ Study: long-term efficacy of uveoscleral outflow enhancement for glaucoma ➤ FDA grants expanded indication for fluocinolone acetonide intravitreal implant ➤ First patient dosed in Phase 1/2 gene therapy trial targeting Stargardt disease ➤ Merger complete ➤ ASCRS news and events
➤ FDA accepts new drug application for pharmaceutical aiming to treat pediatric myopia ➤ FDA approves treatment for macular telangiectasia type 2 ➤ Survey reveals perspectives of patients with glaucoma ➤ New wearable vision testing platform ➤ Seeking Fast Track Designation for investigational treatment of neuropathic corneal pain ➤ Fast Track Designation granted to gene therapy targeting X-linked retinoschisis ➤ ASCRS news and events
➤ Proof-of-concept trial for intravitreal implant for glaucoma patients ➤ Phase 3 study evaluating intravitreal gene therapy for wet AMD ➤ New analysis shows differentiation of investigational glaucoma treatment ➤ IND studies to investigate gene therapy for dry AMD ➤ ASCRS news and events
➤ FDA approves new viscoelastic system ➤ Expanded label approved for geographic atrophy treatment ➤ Biologics application accepted for aflibercept biosimilar ➤ Update on gene therapy program ➤ ASCRS news and events
In his introduction to the “Interventional glaucoma” bonus issue of EyeWorld, Chief Medical Editor Sumit “Sam” Garg, MD, shared some of his personal experiences in this space and what topics readers can expect to learn more about.
Glaucoma Editor Manjool Shah, MD, provided his thoughts on the evolution of interventional glaucoma.
MIGS has continued to expand in its application for a wide variety of patients with varying degrees of glaucoma. Several physicians discussed where various MIGS procedures fit into interventional glaucoma, including applications for standalone MIGS and how it continues to play a role in conjunction with cataract surgery.
Two glaucoma specialists spoke with EyeWorld about the current role of SLT, as well as products in development and further research in the glaucoma laser space.
While glaucoma treatment is shifting toward a more interventional approach, two physicians said the use of drop therapy is alive and well. It is trending toward being an adjunctive therapy as more ophthalmologists are beginning to figure out what pharmaceutical and procedural combinations best suit their patients.
Many MIGS procedures are proving useful and accessible not just to the glaucoma specialist but to comprehensive ophthalmologists as well. Two ophthalmologists discussed who should be performing glaucoma surgery, as well as ways to learn and stay fresh with some of these techniques.